FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2977345063> ?p ?o ?g. }

• W2977345063 endingPage "e0222948" @default.
• W2977345063 startingPage "e0222948" @default.
• W2977345063 abstract "Focal segmental glomerulosclerosis (FSGS) accounts for about 40% of all nephrotic syndrome cases in adults. The presence of several potential circulating factors has been suggested in patients with primary FSGS and particularly in patients with recurrent disease after transplant. Irrespectively of the nature of the circulating factors, this study was aimed at identifying early glomerular/podocyte-specific pathways that are activated by the sera of patients affected by FSGS. Kidney biopsies were obtained from patients undergoing kidney transplantation due to primary FSGS. Donor kidneys were biopsied pre-reperfusion (PreR) and a subset 1–2 hours after reperfusion of the kidney (PostR). Thirty-one post reperfusion (PostR) and 36 PreR biopsy samples were analyzed by microarray and gene enrichment KEGG pathway analysis. Data were compared to those obtained from patients with incident primary FSGS enrolled in other cohorts as well as with another cohort to correct for pathways activated by ischemia reperfusion. Using an ex-vivo cell-based assay in which human podocytes were cultured in the presence of sera from patients with recurrent and non recurrent FSGS, the molecular signature of podocytes exposed to sera from patients with REC was compared to the one established from patients with NON REC. We demonstrate that inflammatory pathways, including the TNF pathway, are primarily activated immediately after exposure to the sera of patients with primary FSGS, while phagocytotic pathways are activated when proteinuria becomes clinically evident. The TNF pathway activation by one or more circulating factors present in the sera of patients with FSGS supports prior experimental findings from our group demonstrating a causative role of local TNF in podocyte injury in FSGS. Correlation analysis with clinical and histological parameters of disease was performed and further supported a possible role for TNF pathway activation in FSGS. Additionally, we identified a unique set of genes that is specifically activated in podocytes when cultured in the presence of serum of patients with REC FSGS. This clinical translational study supports our prior experimental findings describing a potential role of the TNF pathway in the pathogenesis of FSGS. Validation of these findings in larger cohorts may lay the ground for the implementation of integrated system biology approaches to risk stratify patients affected by FSGS and to identify novel pathways relevant to podocyte injury." @default.
• W2977345063 created "2019-10-10" @default.
• W2977345063 creator A5018962385 @default.
• W2977345063 creator A5021600258 @default.
• W2977345063 creator A5024103223 @default.
• W2977345063 creator A5034864437 @default.
• W2977345063 creator A5035299028 @default.
• W2977345063 creator A5036869763 @default.
• W2977345063 creator A5039320136 @default.
• W2977345063 creator A5043991592 @default.
• W2977345063 creator A5065478151 @default.
• W2977345063 creator A5068093776 @default.
• W2977345063 creator A5073141203 @default.
• W2977345063 creator A5078381271 @default.
• W2977345063 creator A5088470577 @default.
• W2977345063 creator A5091542186 @default.
• W2977345063 date "2019-10-03" @default.
• W2977345063 modified "2023-10-16" @default.
• W2977345063 title "Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis" @default.
• W2977345063 cites W1519743429 @default.
• W2977345063 cites W1839562188 @default.
• W2977345063 cites W1972590357 @default.
• W2977345063 cites W1981709521 @default.
• W2977345063 cites W1992568418 @default.
• W2977345063 cites W1992627136 @default.
• W2977345063 cites W2009132304 @default.
• W2977345063 cites W2017263183 @default.
• W2977345063 cites W2030084418 @default.
• W2977345063 cites W2061519721 @default.
• W2977345063 cites W2062155289 @default.
• W2977345063 cites W2062986439 @default.
• W2977345063 cites W2070063270 @default.
• W2977345063 cites W2099234469 @default.
• W2977345063 cites W2105893193 @default.
• W2977345063 cites W2110405088 @default.
• W2977345063 cites W2142895007 @default.
• W2977345063 cites W2144611229 @default.
• W2977345063 cites W2155859235 @default.
• W2977345063 cites W2169110444 @default.
• W2977345063 cites W2223702130 @default.
• W2977345063 cites W2323753285 @default.
• W2977345063 cites W2330129357 @default.
• W2977345063 cites W2478556254 @default.
• W2977345063 cites W2593771998 @default.
• W2977345063 cites W2625969875 @default.
• W2977345063 cites W2800466585 @default.
• W2977345063 cites W2934283619 @default.
• W2977345063 cites W2946825671 @default.
• W2977345063 cites W2966398979 @default.
• W2977345063 doi "https://doi.org/10.1371/journal.pone.0222948" @default.
• W2977345063 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6776339" @default.
• W2977345063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31581251" @default.
• W2977345063 hasPublicationYear "2019" @default.
• W2977345063 type Work @default.
• W2977345063 sameAs 2977345063 @default.
• W2977345063 citedByCount "16" @default.
• W2977345063 countsByYear W29773450632020 @default.
• W2977345063 countsByYear W29773450632021 @default.
• W2977345063 countsByYear W29773450632022 @default.
• W2977345063 countsByYear W29773450632023 @default.
• W2977345063 crossrefType "journal-article" @default.
• W2977345063 hasAuthorship W2977345063A5018962385 @default.
• W2977345063 hasAuthorship W2977345063A5021600258 @default.
• W2977345063 hasAuthorship W2977345063A5024103223 @default.
• W2977345063 hasAuthorship W2977345063A5034864437 @default.
• W2977345063 hasAuthorship W2977345063A5035299028 @default.
• W2977345063 hasAuthorship W2977345063A5036869763 @default.
• W2977345063 hasAuthorship W2977345063A5039320136 @default.
• W2977345063 hasAuthorship W2977345063A5043991592 @default.
• W2977345063 hasAuthorship W2977345063A5065478151 @default.
• W2977345063 hasAuthorship W2977345063A5068093776 @default.
• W2977345063 hasAuthorship W2977345063A5073141203 @default.
• W2977345063 hasAuthorship W2977345063A5078381271 @default.
• W2977345063 hasAuthorship W2977345063A5088470577 @default.
• W2977345063 hasAuthorship W2977345063A5091542186 @default.
• W2977345063 hasBestOaLocation W29773450631 @default.
• W2977345063 hasConcept C126322002 @default.
• W2977345063 hasConcept C142724271 @default.
• W2977345063 hasConcept C2777146197 @default.
• W2977345063 hasConcept C2777390665 @default.
• W2977345063 hasConcept C2777747828 @default.
• W2977345063 hasConcept C2778415529 @default.
• W2977345063 hasConcept C2778653478 @default.
• W2977345063 hasConcept C2778930706 @default.
• W2977345063 hasConcept C2779561371 @default.
• W2977345063 hasConcept C2780091579 @default.
• W2977345063 hasConcept C2780368995 @default.
• W2977345063 hasConcept C2781087799 @default.
• W2977345063 hasConcept C71924100 @default.
• W2977345063 hasConceptScore W2977345063C126322002 @default.
• W2977345063 hasConceptScore W2977345063C142724271 @default.
• W2977345063 hasConceptScore W2977345063C2777146197 @default.
• W2977345063 hasConceptScore W2977345063C2777390665 @default.
• W2977345063 hasConceptScore W2977345063C2777747828 @default.
• W2977345063 hasConceptScore W2977345063C2778415529 @default.
• W2977345063 hasConceptScore W2977345063C2778653478 @default.
• W2977345063 hasConceptScore W2977345063C2778930706 @default.
• W2977345063 hasConceptScore W2977345063C2779561371 @default.

• next